Advanced Peptide Therapy governance

MFMD reviews the accepted program’s provider authority, documentation, monitoring, consent, product sourcing, evidence limitations, and escalation process. Clinical decisions remain with the qualified treating prescriber. There is no blanket approval of a peptide list, supplier, or combination simply because the program appears in the estimator.

Implementation defines the clinical foundation, provider roles, evaluation and ordering process, consent, monitoring, documentation, and escalation. Individual peptides and proposed combinations (“stacks”) are discussed by the provider and assigned Medical Director and included only after clinical and current regulatory review. Documents are customized to the facility’s accepted program; discussion is not a promise that every requested compound will be accepted.

Off-label use refers to a use of an FDA-approved drug outside its approved labeling. A substance that has never been approved is a different issue. Neither physician discussion nor the phrase “research use only” establishes that an unapproved product can be marketed, compounded, or administered to patients. MFMD assesses the specific product and proposed use.

FDA identifies potential significant safety risks for certain substances proposed for compounding. A product’s status, evidence, route, and lawful source must be checked at the time of review. An advisory-committee discussion is not itself FDA approval. MFMD does not advertise a universal approved peptide list or guarantee access to a requested compound.

MFMD supports an RN-executed model for aesthetic medicine and IV/injection services within the nurse’s authorized role, with the required patient evaluation, orders, training, and supervision in place. Weight management, BHRT/TRT, and Advanced Peptide Therapy require at least one NP or PA on the facility roster under MFMD’s service model. You may identify a planned APP while estimating; the provider and collaboration arrangements must be confirmed before activation. One APP is included in the base fee. An RN or electrologist does not replace the APP required for Medical Wellness.

One wellness service group is $1,500/month; both groups together are $2,000/month. Collaboration or supervision for 1 APP is included; each additional APP is $500/month and each electrologist addition is $500/month. Initial setup is $2,000 for one group or $3,000 for both, including the first 30 days of governance. Adding the second group to an accepted existing operation is $1,000; a new procedure protocol within an accepted group is $250. The proposal confirms which setup applies.

Enter the facility ZIP, choose the applicable services, and describe your team and existing protocols. Review your estimate before providing contact details. MFMD then reviews the operating facts and documents, confirms the assigned physician, initial on-site assessment, scheduled visits, and any required treatment-day arrangements, and issues the agreed scope and start date. An EMR is required and must be in use with physician access before governance begins. You may complete a planning estimate while choosing the platform; paper-only clinical operations are not accepted. No clinical services begin merely because a form was submitted.

Clinical review of pharmacies, products, and formularies is included. When MFMD participation is needed to establish or maintain up to 2 approved accounts, account setup and administration adds $500/month. The same account-support charge applies to an APP-led Medical Wellness practice or an RN-executed aesthetic/IV practice; it does not change professional authority. For example, weight management plus Advanced Peptide Therapy in one group, with one included APP and account administration, is $2,000/month; initial setup for that group is $2,000. Medication, pharmacy, device, and third-party charges are separate.